NCT04254471 2020-02-05
This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients
Haihe Biopharma Co., Ltd.
Phase 2/3 Unknown
Haihe Biopharma Co., Ltd.
Haihe Biopharma Co., Ltd.
Taichung Tzu Chi Hospital